|
|
Blood, 15 July 2007, Vol. 110, No. 2, pp. 479-484.
Prepublished online as a Blood First Edition Paper on March 5, 2007; DOI 10.1182/blood-2006-10-054601.
 Previous Article | Next Article 
Submitted October 30, 2006
Accepted February 7, 2007
TNM classification system for primary cutaneous lymphomas other than mycosis fungoides and Sezary syndrome: a proposal of the International Society for Cutaneous Lymphomas (ISCL) and the cutaneous lymphoma task force of the European Organization of Research and Treatment of Cancer (EORTC)
Youn H Kim*, Rein Willemze, Nicola Pimpinelli, Sean Whittaker, Elise A Olsen, Annamari Ranki, Reinhard Dummer, and Richard T Hoppe
Dept of Dermatology, Stanford Comprehensive Cancer Center, Stanford, CA, United States
Dept of Dermatology, Leiden University Medical Center, Leiden, Netherlands
Dept of Dermatological Sciences, University of Florence, Florence, Italy
Skin Tumour Unit, St. Thomas' Hospital, London, United Kingdom
Dept of Medicine, Divisions of Dermatology & Oncology, Duke University Medical Center, Durham, NC, United States
Dept of Dermatology & Venereal Diseases, Helsinki University Hospital, Helsinki, Finland
Dept of Dermatology, University Hospital Zurich, Zurich, Switzerland
Dept of Radiation Oncology, Stanford Comprehensive Cancer Center, Stanford, CA, United States
* Corresponding author; email: younkim{at}stanford.edu.
Currently available staging systems for non-Hodgkin's lymphomas are not useful for clinical staging classification of most primary cutaneous lymphomas. The TNM system used for mycosis fungoides (MF) and Sezary syndrome (SS) is not appropriate for other primary cutaneous lymphomas. A usable, unified staging system would improve the communication about the state of disease, selection of appropriate management, standardization of enrollment/response criteria in clinical trials, and collection/analysis of prospective survival data. Towards this goal, during the recent meetings of the International Society for Cutaneous Lymphomas (ISCL) and the cutaneous lymphoma task force of the European Organization of Research and Treatment of Cancer (EORTC), the representatives have established a consensus proposal of a TNM classification system applicable for all primary cutaneous lymphomas other than MF and SS. Due to the clinical and pathologic heterogeneity of the cutaneous lymphomas, the currently proposed TNM system is meant to be primarily an anatomic documentation of disease extent and not to be used as a prognostic guide.
 CiteULike  Connotea  Del.icio.us  Digg  Reddit  Technorati What's this?
This article has been cited by other articles:
|
|
|
|
 
B. F. Chong, A. J. Wilson, H. M. Gibson, M. S. Hafner, Y. Luo, C. J. Hedgcock, and H. K. Wong
Immune Function Abnormalities in Peripheral Blood Mononuclear Cell Cytokine Expression Differentiates Stages of Cutaneous T-Cell Lymphoma/Mycosis Fungoides
Clin. Cancer Res.,
February 1, 2008;
14(3):
646 - 653.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
E. Olsen, E. Vonderheid, N. Pimpinelli, R. Willemze, Y. Kim, R. Knobler, H. Zackheim, M. Duvic, T. Estrach, S. Lamberg, et al.
Revisions to the staging and classification of mycosis fungoides and Sezary syndrome: a proposal of the International Society for Cutaneous Lymphomas (ISCL) and the cutaneous lymphoma task force of the European Organization of Research and Treatment of Cancer (EORTC)
Blood,
September 15, 2007;
110(6):
1713 - 1722.
[Abstract]
[Full Text]
[PDF]
|
|
|
| |
